Related Experiment Video

Updated: May 28, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Prenatal and newborn screening for CFTR mutations: the difficulties of prediction

Martin J Schwarz1

  • 1Regional Molecular Genetics Service, Genetic Medicine, 6th Floor, St Mary's Hospital, Oxford Road, Manchester, M13 9WL, UK.

Clinical Biochemistry
|November 1, 2011
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
15:12

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae

Published on: May 10, 2014

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice
08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

Related Experiment Videos

Last Updated: May 28, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
15:12

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae

Published on: May 10, 2014

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice
08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...

Articles linked to this work by shared authors, journal, and citation graph.

Analysis of genomic CFTR DNA.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2004

Cascade carrier-testing in cystic fibrosis.

Paediatric respiratory reviews·2003

Lipoprotein(a) repeat testing patterns and clinical significance of changes between repeat measurements: a real-world reference change value-based retrospective analysis.

Clinical biochemistry·2026

Primer part 3 - evaluating, disseminating and sustaining a laboratory quality improvement project.

Clinical biochemistry·2026

Detection of individual false-low total bilirubin results in neonates and young infants using the bilirubin-to-icteric index ratio.

Clinical biochemistry·2026

From selective testing to actionable prevention: The VALOR-ED pathway.

Clinical biochemistry·2026

Intraoperative PTH monitoring during parathyroid surgery: when 10 minutes is not enough-Can delayed decline be predicted?

Clinical biochemistry·2026

Non-steroidal anti-inflammatory drugs and CYP2C9 - Impacts of genetics and phenoconversion on the risk of adverse effects.

Clinical biochemistry·2026

Deployment-Matched Allocation of PBE, mBJ, and HSE06 for Band-Gap Screening Under Chemical and Protocol Shifts.

Journal of computational chemistry·2026

A Fast and Parallelized Procedure for Checking Molecular Dynamics 3D Structure.

Journal of computational chemistry·2026

Evaluating PBE-D3/M06 for copper-catalyzed carbon chemistry: Kinetic barriers and mechanistic insights.

The Journal of chemical physics·2026

Scaffold-shift uncertainty calibration in molecular activity prediction: A multi-target benchmark of coverage, efficiency, and risk-aware selection.

Computational biology and chemistry·2026

Two‑tier prediction framework with OR‑voting for real‑time freeway secondary-crash prediction: Balancing sensitivity and specificity.

Traffic injury prevention·2026

ResNet-assisted coarse-grained modeling of CH4-CO2 hydrates: Linking structural descriptors to interaction potentials.

The Journal of chemical physics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us